Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.061 | 0.04 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.04 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.05 |